Cancer affects one in three men and one in four women in Australia by the time they are 75 years old.

Survival rates for many common types of cancers has increased by more than 30 per cent in the past two decades due to treatment improvements and new interventions brought about by research.

The annual cost of treating cancer in Australia is more than $2 billion.

If we reduced cancer deaths in the next 40 years by 20 per cent we would save $18 billion.

The benefits of particle therapy include enhanced tumour control and treatment, better patient outcomes and reduced morbidity.  It is also reduces the risk of radiation induced secondary cancers.

Australia has the opportunity to build on it internationally competitive cancer research status.

Australia’s academic and private sectors can benefit from, and capitalise on, internationally competitive clinical, physics and biology research in the particle therapy field.

Particle therapy also offers access to world leading, cutting-edge medical, biology and physics research which traverses industries, such as health, biotechnology, space sciences, agriculture, advanced mathematics and engineering.

The Westmead precinct is one of the largest health, research, education and training precincts in the world and Westmead is located within one of the largest and fastest growing populations in Australia.

The Westmead precinct is ideally placed to host Australia’s first Particle Treatment and Research Centre due to its scale, expertise and partnerships, its strategic location close to major domestic and international transport corridors and facilities and its unparalleled development potential.

The proposal for establishing a National Particle Treatment and Research Centre at the Westmead precinct has the commitment from a diverse range of service partners and stakeholders who have contributed significant time, skills and expertise to develop the proposal.

We have prepared a document that outlines the technology, the opportunities and the benefits and we are keen to discuss why Australia needs the technology and why the clinical, education and research capability at the Westmead precinct makes it the ideal location.

Read more

Download the document summarising the proposal

If you have difficulties downloading or accessing PDFs please contact us and we can arrange for an alternative format for you.


Please note: The reseracher pictured is Professor Jacob George. Professor George is a Professor of the University of Sydney and Head of the Department of Gastroenterology & Hepatology at Westmead Hospital. He is not the author of the particle therapy document mentioned in this article. 
A Westmead researcher sits at a microscope

Subscribe to our newsletter

icon of an envelope with a piece of paper coming out of it with an

Sign up to receive our weekly newsletter. Editions are circulated on Mondays.

Go to our sign-up page